Want to see ALURD full AI Analyst Report?

Allurion Technologies (ALURD) Price & Analysis

305 Followers

ALURD Stock Chart & Stats

$0.80

-$0.76(-9.72%)

At close: Jan 08 4:00 PM EST

$0.80

-$0.76(-9.72%)

Day’s Range― - ―

52-Week Range$2.67 - $49.94

Previous CloseN/A

VolumeN/A

Average Volume (3M)88.72K

Market Cap

$5.50M

Enterprise Value$29.12M

Total Cash (Recent Filing)$5.06M

Total Debt (Recent Filing)$29.45M

Price to Earnings (P/E)―

Beta2.56

Next Earnings

Aug 19, 2026

EPS Estimate

-5.7

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-56.40

Shares Outstanding1,000,417

10 Day Avg. Volume45,410

30 Day Avg. Volume88,723

Financial Highlights & Ratios

PEG Ratio-0.02

Price to Book (P/B)-0.12

Price to Sales (P/S)0.61

P/FCF Ratio-0.32

Enterprise Value/Market Cap5.29

Enterprise Value/Revenue2.31

Enterprise Value/Gross Profit4.39

Enterprise Value/Ebitda-0.75

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-20.25

Revenue Forecast (FY)$13.70M

Bulls Say, Bears Say

Bulls Say

Cost ManagementOperating expenses of $9.4M were down 48% year over year, as the company continues to closely control spending while prioritizing its growth initiatives.

Sales PerformanceQ3 sales were $2.7M vs the $2.1M Street estimate.

Strategic RealignmentALUR used the quarter to implement the strategy it outlined in August of realigning toward distributors with physician networks that prescribe GLP-1s.

Bears Say

Gross Margin DeclineQ3 gross margin was 49%, down from 58% last year due to the decline in sales and lower production volumes leading to less absorption of labor and overhead costs.

Revenue ShortfallRevenue was $3.4M, which fell short of the $5.2M consensus.

Sales ImpactSales were hurt by the intra-quarter decision to realign toward distributors with physician networks that prescribe GLP-1s.

Allurion Technologies News

Allurion Technologies Board Member Resigns, Audit Chair Vacant

The latest update is out from Allurion Technologies ( ($ALURD) ). Allurion Technologies, Inc. reported that on June...

3d ago

ALURD FAQ

What was Allurion Technologies’s price range in the past 12 months?

Allurion Technologies lowest stock price was $2.67 and its highest was $49.94 in the past 12 months.

What is Allurion Technologies’s market cap?

Allurion Technologies’s market cap is $5.50M.

When is Allurion Technologies’s upcoming earnings report date?

Allurion Technologies’s upcoming earnings report date is Aug 19, 2026 which is in 46 days.

How were Allurion Technologies’s earnings last quarter?

Currently, no data Available

Is Allurion Technologies overvalued?

According to Wall Street analysts Allurion Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Allurion Technologies pay dividends?

Allurion Technologies does not currently pay dividends.

What is Allurion Technologies’s EPS estimate?

Allurion Technologies’s EPS estimate is -5.7.

How many shares outstanding does Allurion Technologies have?

Allurion Technologies has 1,000,417 shares outstanding.

What happened to Allurion Technologies’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Allurion Technologies?

Currently, no hedge funds are holding shares in ALURD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Allurion Technologies

Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.